Faculty Profiles - OHMORI Iori

MISC - OHMORI Iori

Division display 61 - 80 of about 84 ／ All the affair displays >>

Calpain inhibits endocytosis by cleaving amphiphysin I

Yumei Wu, Kazuhito Tomizawa, Shuang Liang, Iori Ohmori, Teiichi Nishiki, Kohji Takei, Hideki Matsui

NEUROSCIENCE RESEARCH 55 S76 - S76 2006

Relationship between absence seizures and GABA(A) receptor.

M Ito, I Ohmori, T Nakahori, T Takata, H Yoshinaga, Y Ohtsuka

EPILEPSIA 46 16 - 16 2005

Intermittent Explosive Disorder after Epilepsy Surgery for Mesial Temporal Lobe Epilepsy

和田健, 山田了士, 鈴木啓嗣, 黒田重利, 榎日出夫, 大守伊織, 真柳佳昭

精神医学 46 ( 9 ) 947 - 953 2004.9

MECP2 mutations in 217 patients with RTT syndrome.

Kondo, I, Ishihara, I, M Miyamoto, T Matsuishi, Y Yamashita, K Kuwajima, T Iwai, S Endo, M Sone, H Yamagata, Y Tabara, Ohmori, I, E Oka

AMERICAN JOURNAL OF HUMAN GENETICS 73 ( 5 ) 333 - 333 2003.11

P-01 乳児重症ミオクロニーてんかんの中核群と辺縁群の関連

大塚頌子, 大守伊織, 荻野竜也, 小林勝弘, 岡〓次

日本てんかん学会プログラム・予稿集 ( 37 ) 149 - 149 2003.10

乳児重症ミオクロニーてんかんと遺伝子 (特集てんかんの基礎と最近の話題)

大守伊織, 荻野竜也, 大塚頌子

小児科診療 66 ( 10 ) 1699 - 1704 2003.10

I F9 Treatment of epilepsy with electrical status epilepticus during slow sleep and its related epilepsy

Inutsuka Miki, Ootsuka Yoko, Kobayashi Katsuhiro, Ohmori Iori, Oka Eiji

( 36 ) 150 - 150 2002.9

IN B10 Paroxysmal movement disorder and severe myoclonic epilepsy in infancy :

Ohtsuka Yoko, Ohmori Iori, Ogino Tatsuya, Ouchida Mamotu, Shimizu Kenji, Oka Eiji

( 36 ) 256 - 256 2002

Mutation spectrum and genotype-phenotype correlation of MECP2 in 100 Japanese patients with Rett syndrome.

T Fukuda, T Matsuichi, R Morishita, Y Yamashita, Ohmori, I, Horiuchi, I, K Kuwajima, H Nitta, H Yamagata, Kondo, I

AMERICAN JOURNAL OF HUMAN GENETICS 69 ( 4 ) 595 - 595 2001.10

A-10 多小脳回に合併するてんかんの特徴

大塚頌子, 小林勝弘, 太田穂高, 大守伊織, 榎日出夫, 吉永治美, 岡〓次

日本てんかん学会プログラム・予稿集 ( 34 ) 95 - 95 2000.9

B-13 複雑部分発作の発作時脳波の有用性と限界

吉永治美, 大守伊織, 浅野孝, 秋山倫之, 岡〓次

日本てんかん学会プログラム・予稿集 ( 34 ) 116 - 116 2000.9

てんかん外科手術後に著明な衝動性こう進を呈した側頭葉てんかんの2例

和田健, 山田了士, 河本俊彦, 鈴木啓嗣, 黒田重利, 榎日出夫, 大守伊織

てんかん研究 18 ( 1 ) 49 2000.2

閉眼過敏および図形過敏反応出現時の鳥距溝動脈血流速度

眞田敏, 大守伊織, 太田穂高, 寺崎智行

臨床脳波 42 ( 1 ) 61 - 64 2000

Clinical applications and the effect of mexiletine on refractory epilepsies

H. Enoki, H. Hata, I. Ohmori, S. Maniwa, H. Ohta, K. Kobayashi

No To Hattatsu 32 ( 1 ) 29 - 34 2000

Language：Japanese

Twenty-four patients with refractory epilepsy were treated with mexiletine as an additional antiepileptic drug. As the initial responses, seizures were decreased by 50% or more in 7 (46.7%) of 15 patients with symptomatic partial epilepsy (SPE), in none of 7 with symptomatic generalized-epilepsy (SGE), and in 1 of 2 with undetermined epilepsy. Seizures increased in 3 patients (20.0%) with SPE, and in 3 (42.9%) with SGE. Concerning seizure types, mexiletine had significant effects on 1 of 2 patients with simple partial seizures, on 7 of 13 with complex partial seizures, on 1 of 5 with secondarily generalized seizures, and on 1 of 8 with tonic seizures. No patients with a myoclonic seizure or atypical absence improved. Exacerbation of the seizures was observed in 2 of 13 patients with complex partial seizures, in 1 of 5 with secondarily generalized seizures, in 3 of 8 with tonic seizures, and in 2 of 3 with myoclonic seizures. Partial seizures were controlled well, whereas generalized seizures sometimes worsened. EEG improved in 3 patients with SPE
decrease of focal spikes in 2 patients and disappearance of secondary generalization in 1. Follow-up for more than 3 months showed seizures to be lessened in 2 patients. Mexiletine is useful for the treatment of refractory epilepsies, especially SPE.

DOI： 10.11251/ojjscn1969.32.29

Scopus

PubMed

researchmap

B-22 てんかん外科手術後に著名な衝動性亢進を呈した側頭葉てんかんの2例

和田健, 山田了士, 河本俊彦, 鈴木啓嗣, 黒田重利, 榎日出夫, 大守伊織

日本てんかん学会プログラム・予稿集 ( 33 ) 130 - 130 1999.10